US3737522A - Oral compositions for calculus retardation - Google Patents
Oral compositions for calculus retardation Download PDFInfo
- Publication number
- US3737522A US3737522A US00051356A US3737522DA US3737522A US 3737522 A US3737522 A US 3737522A US 00051356 A US00051356 A US 00051356A US 3737522D A US3737522D A US 3737522DA US 3737522 A US3737522 A US 3737522A
- Authority
- US
- United States
- Prior art keywords
- calculus
- carbonyldiphosphonate
- carbonyldiphosphonates
- oral compositions
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract description 43
- 230000015572 biosynthetic process Effects 0.000 abstract description 12
- 239000000606 toothpaste Substances 0.000 abstract description 12
- 229940034610 toothpaste Drugs 0.000 abstract description 10
- 206010044029 Tooth deposit Diseases 0.000 abstract description 7
- 208000006558 Dental Calculus Diseases 0.000 abstract description 6
- 239000002324 mouth wash Substances 0.000 abstract description 4
- 229940051866 mouthwash Drugs 0.000 abstract description 3
- XYORSKKUGAGNPC-UHFFFAOYSA-N phosphonocarbonylphosphonic acid Chemical class OP(O)(=O)C(=O)P(O)(O)=O XYORSKKUGAGNPC-UHFFFAOYSA-N 0.000 description 33
- -1 alkali metal (e.g. Chemical class 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000001506 calcium phosphate Substances 0.000 description 7
- 235000011010 calcium phosphates Nutrition 0.000 description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000003082 abrasive agent Substances 0.000 description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000002272 anti-calculus Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 238000011321 prophylaxis Methods 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- VOCLSHIYPGYWJW-UHFFFAOYSA-N [dihydroxy(phosphono)methyl]phosphonic acid Chemical compound OP(=O)(O)C(O)(O)P(O)(O)=O VOCLSHIYPGYWJW-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 230000009920 chelation Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 229940081974 saccharin Drugs 0.000 description 3
- 235000019204 saccharin Nutrition 0.000 description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
- BLOYBSBBTASDGD-UHFFFAOYSA-J tetrasodium;diphosphonatomethanone Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)C(=O)P([O-])([O-])=O BLOYBSBBTASDGD-UHFFFAOYSA-J 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- MDAXKAUIABOHTD-UHFFFAOYSA-N 1,4,8,11-tetraazacyclotetradecane Chemical compound C1CNCCNCCCNCCNC1 MDAXKAUIABOHTD-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical class O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 1
- HANVTCGOAROXMV-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine;urea Chemical class O=C.NC(N)=O.NC1=NC(N)=NC(N)=N1 HANVTCGOAROXMV-UHFFFAOYSA-N 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001581 salivary duct Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- BMDWJXWRRNOMEZ-UHFFFAOYSA-N tetraazanium;diphosphonatomethanone Chemical compound [NH4+].[NH4+].[NH4+].[NH4+].[O-]P([O-])(=O)C(=O)P([O-])([O-])=O BMDWJXWRRNOMEZ-UHFFFAOYSA-N 0.000 description 1
- IAPWVYBJKZBIDM-UHFFFAOYSA-J tetrapotassium;diphosphonatomethanone Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)C(=O)P([O-])([O-])=O IAPWVYBJKZBIDM-UHFFFAOYSA-J 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
Definitions
- the field of this invention is oral compositions which term is used herein to designate products which in the ordinary course of usage are retained in the oral cavity for a time sufiicient to contact substantially all of the dental surfaces, but are not intentionally ingested.
- Such products include, for example, dentifrices, mouthwashes, prophylaxis pastes and topical solutions.
- Dental calculus or tartar as it is sometimes called, is a deposit which forms on the surfaces of the teeth at the gingival margin. Snpragingival calculus appears principally in the areas near the orifices of the salivary ducts; e.g., on the lingual surfaces of the lower anterior teeth and on the buccal surfaces of the upper first and second molars, and on the distal surfaces of the posterior molars.
- Mature calculus consists of an inorganic portion which is largely calcium phosphate arranged in a hydroxyapatite crystal lattice structure similar to bone, enamel and dentine.
- An organic portion is also present and consists of desquamated epithelial cells, leukocytes, salivary sediment, food debris and various types of microorganisms.
- the mature calculus As the mature calculus develops, it becomes visibly white or yellowish in color unless stained or discolored by some extraneous agency. vIn addition to being unsightly and undesirable from an aesthetic standpoint, the mature calculus deposits are constant sources of irritation of the gingiva and thereby are a contributory factor to gingivitis and other diseases of the supporting structures of the teeth, the irritation decreasing the resistance of tissues to endogenous and exogenous organisms.
- the chemical approach to calculus inhibition generally involves chelation of calcium ion which prevents the calculus from forming and/ or breaks down mature calculus by removing calcium.
- a number of chelating agents have been employed for this purpose. See, for example, British Pat. 490,384, granted Feb. 15, 1937, which discloses oral compositions containing ethylenediaminetetraacetic acid, nitrilotriacetic acid and related compounds as anticalculus agents; German Auslegeschrift 1,149,138, published May 22, 1963, which discloses certain water-soluble diglycolates as anticalculus agents; and U.S. Pat. 1,561,206 which discloses oral compositions containing various sugar lactones for this purpose.
- the carbonyldiphosphonates employed in the compositions of this invention resist hydrolysis in aqueous products and therefore remain in an active form throughout the normal shelf-life of such products.
- This invention is an oral composition eflective in inhibiting the formation of dental calculus without adversely affecting the tooth structure
- a pharmaceutically acceptable carbonyldiphosphonate salt such as alkali metal (e.g., sodium and potassium), alkaline earth metal (e.g., calcium and magnesium), non-toxic heavy metal (e.g., stannous and indium), and ammonium or low molecular weight substituted ammonium (e.g., mono-, di-, and triethanolammonium) salts
- a pharmaceutically acceptable carbonyldiphosphonate salt such as alkali metal (e.g., sodium and potassium), alkaline earth metal (e.g., calcium and magnesium), non-toxic heavy metal (e.g., stannous and indium), and ammonium or low molecular weight substituted ammonium (e.g., mono-, di-, and triethanolammonium) salts
- a carrier suitable for use in the oral cavity the pH of said composition being in the range from about 5.0
- dihydroxymethanediphosphonic acid exists in equilibrum with the pharmaceutically acceptable carbonyldiphosphonate salt as follows:
- carbonyldiphosphonate as employed herein encompasses dihydroxymethanediphosphonic acid and salts as well as the carbonyldiphosphonate salts, collectively.
- Carbonyldiphosphonates can be prepared in any convenient manner.
- a preferred method is disclosed by Oscar T. Quimby, U.S. Pat. 3,497,313, granted Feb. 24, 1970.
- the use of these compounds in inhibiting the anomalous deposition and mobilization of calcium phosphate by systemic administration is disclosed in the concurrently filed application of Marion D. Francis, Ser. No. 51,355, filed June 30, 1970.
- the concentration of carbonyldiphosphonate in the oral compositions of this invention can range from about .0l% to about 10% by weight.
- Oral compositions which in the ordinary course of usage could he accidentally ingested should contain lower concentrations of carbonyldiphosphonate.
- a mouthwash in accordance with this invention preferably contains less than about 3% by weight of carbonyldiphosphonate.
- Dentifrice compositions, topical solutions and prophylaxis pastes, the latter to be administered professionally, can contain up to about 10% by weight, preferably from about 0.1% to about 5.0% by Weight of carbonyldiphosphonate.
- the pH of the composition of this invention can range from about 5.0 to about 11. Below about pH 5.0 damage to the dental enamel can occur in spite of the relative safety of the carbonyldiphosphonates. Above about pH 11.0 difiiculty is encountered in formulating products having satisfactory flavor and mildness. A preferred pH range is from about 7.0 to about 10. The pH of the composition, of course, is determinative of the predominant salt form of the carbonyldiphosphonates present therein.
- Rat Calculus Study Two groups of 20 to 21-day old Holtzman-Sprague- Dawley strain rats, each group comprising one male and one female member of each of 10 litters, are employed in this test, one group serving as the control and the other serving as the test group. Both groups of animals are placed on a calculus inducing diet consisting of 63% cornstarch, 32% non-fat dry milk, 2% liver powder and 3% cellulflour. Topical applications of a 0.5% aqueous solution of the carbonyldiphosphonate to be tested, adjusted to pH 10,0, are made on the teeth of each of the animals in the test group for about one minute twice daily, five days per week for two weeks. Similar applications of water are made to each animal in the control group during the experimental period.
- the animals are sacrificed and their molar are graded for severity of calculus by assessing the area and depth of accumulation on eacth of the 44 dental surfaces examined in each animal. Grading is made on a -3 scale for each surface, 0 being no detectable calcified deposits, 3 being coverage of 50100% of the surface with a thick deposit and intermediate values representing gradations between these extremes.
- the total calculus score for each animal is determined by adding the grades for each of the 44 surfaces.
- Crystal Growth Inhibition Determination v in this way interfere with the normal formation of calciu y y p ite item sqlut o
- the fl y f carbonyldiphosphonates in inhibiting crystal growth was demonstrated by the Crystal Growth Inhibition Determination which was conducted as follows:
- ethylenediaminetetraacetic acid and nitrilotriacetic acid which have 'been suggested for use as anticalculus agents in the art fail to inhibit crystal growth at molar concentrations of 2.45 l0 respectively. At higher concentrations, these prior art compounds prevent precipitation of calcium phosphate in this test because of their powerful calcium sequestering properties.
- Toothpaste compositions conventionally contain abrasive materials, sudsing agents, binders, humectants, flavoring and sweetening agents.
- the abrasive materials and other adjuncts in the practice of this invention are preferably not sources of much soluble calcium so that the crystal growth inhibiting capacity of carbonyldiphosphonate is not depleted to an extent that its anticalculus activity is impaired.
- conventional abrasives such as dicalcium orthophosphate and calcium carbonate are preferably not used.
- predominantly B-phase calciumpyrophosphate prepared in accordance with the teachings of Schweizer, US. Pat. 3,112,247, granted Nov. 26, 1963, which contains relatively little soluble calcium can be used.
- An especially preferred class of abrasives for use herein are the particulate thermosetting polymerized resins as described by Cooley et al., in US. Pat. 3,070,510, granted Dec. 25, 1962.
- Suitable resins include, for example, melamines, phenolics, ureas, melamine-ureas, melamine-formaldehydes, urea-formaldehydes, melamine-urea-formaldehydes, cross-linked epoxides, and cross-linked polyesters.
- Suitable abrasives include alumina and the insoluble non-calcium metaphosphates such as sodium metaphosphate. Mixtures of abrasives can also be used.
- the total amount of abrasive in the dentifrice embodiments of this invention can range from 0.5% to by weight of the dentifrice.
- toothpastes contain from 20% to 60% by weight of abrasive.
- Abrasive particle size preferably ranges from 2,41. to 20 Suitable sudsing agents are those which are reasonably stable and form suds throughout a wide pH range, preferably non-soap anionic organic synthetic detergents.
- Such agents are water-soluble salts of alkyl sulfate having from to 18 carbon atoms in the alkyl radical, such as sodium lauryl sulfate; water-soluble salts of sulfonated monoglycerides of fatty acids having from 10 to 18 carbon atoms, such as sodium monoglyceride sulfonates; salts of C -C fatty acid amides of taurine, such as sodium N-methyl-N-palmitoyl tauride; salts of C -C fatty acid esters of isethionic acid; and substantially saturated aliphatic acyl amides of saturated monoaminocarboxylic acids having 2 to 6 carbon atoms and in which the acyl radical contains 12 to 16 carbon atoms, such as sodium N-lauroyl sarcoside. Mixtures of two or more sudsing agents can be used.
- the sudsing agent can be present in the dentifrice compositions of this invention in an amount from 0.5% to 5% by weight of the total compositions.
- thickening agents are hydroxyethyl cellulose and water-soluble salts of cellulose ethers such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose.
- Natural gums such as gum karaya, gum arabic, and gum tragacanth can also be used.
- Colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture.
- Thickening agents in an amount from 0.5% to 5.0% by weight of the total composition can be used.
- humectant material in a toothpaste to keep it from hardening.
- Suitable humectants include glycerine, sorbitol, and other edible polyhydric alcohols.
- the humectant can comprise up to about 36% by weight of the toothpaste composition.
- Suitable flavoring agents include oil of Wintergreen, oil of peppermint, oil of spearmint, oil of sassafras, and oil of clove.
- Sweetening agents which can be used include saccharin, dextrose, levulose and sodium cyclamate.
- This composition effectively retards calculus formation without decalcifying dental enamel.
- Toothpaste compositions substantially identical to the composition of Example I are prepared with tetrasodium carbonyldiphosphonate, tetrapotassium carbonyldiphosphonate, dimagnesium carbonyldiphosphonate, monocalcium disodium carbonyldiphosphonate and tetraammonium carbonyldiphosphonate, respectively, rather than dihydroxymethanediphosphonic acid, adjusting the pH to 5.9. These compositions substantially retard calculus formation and do not decalcify dental enamel.
- a prophylaxis paste for use by the dentist for removal of stains and polishing the teeth after mechanical removal of calculus deposits is formulated as follows:
- Toothpowders and the like can be prepared by conventional methods and containing, in addition to the usual ingredients, an amount of carbonyldiphosphonate within the ranges specified herein, to provide an effective means of retarding calculus formation without damaging the tooth structure.
- An oral composition effective in inhibiting the for! mation. ofdental calculus without adversely afiecting tooth structure comprising (1) from about 0.01% ,to about 10% by weight of a member selected from the group consisting of alkali metal carbonyldiphosphonates andalkaline earth metal carbonyldiphosphonates; and (2) a carrier 8 suitable for use in the oral cavity, the pH of the composition being within the range from about 5.0 to about 11.0 2.
- a toothpaste composition comprising (1) from about 0.01% to about 10% by weight of a member selected from the group consisting of alkali metal carbonyldiphosphonates and alkaline earth inetal carbonyldiphosphonates; and I 2) a carrier suitable for use in the oral cavity, the pH of the composition being within the'range from about 5.0 to about 11.0.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
ORAL COMPOSITIONS, SUCH AS TOOTHPASTE, MOUTHWASH, AND THE LIKE, CONTAINING CERTAIN CARBONYLDIPHOSPHONATES AS HEREIN DEFINED WHICH RETARD DENTAL CALCULUS FORMATION WITHOUT DAMAGING TOOTH STRUCTURE.
Description
United States Patent 3,737,522 ORAL COMPOSITIONS FOR CALCULUS RETARDATION Marion D. Francis, Springfield Township, Hamilton County, Ohio, assignor to The Procter & Gamble Company, Cincinnati, Ohio No Drawing. Filed June 30, 1970, Ser. No. 51,356
Int. Cl. A61k 7/16 U.S. Cl. 424-49 2 Claims ABSTRACT OF THE DISCLOSURE Oral compositions, such as toothpaste, mouthwash, and the like, containing certain carbonyldiphosphonates as herein defined which retard dental calculus formation without damaging tooth structure.
BACKGROUND OF THE INVENTION The field of this invention is oral compositions which term is used herein to designate products which in the ordinary course of usage are retained in the oral cavity for a time sufiicient to contact substantially all of the dental surfaces, but are not intentionally ingested. Such products include, for example, dentifrices, mouthwashes, prophylaxis pastes and topical solutions.
Dental calculus, or tartar as it is sometimes called, is a deposit which forms on the surfaces of the teeth at the gingival margin. Snpragingival calculus appears principally in the areas near the orifices of the salivary ducts; e.g., on the lingual surfaces of the lower anterior teeth and on the buccal surfaces of the upper first and second molars, and on the distal surfaces of the posterior molars.
Mature calculus consists of an inorganic portion which is largely calcium phosphate arranged in a hydroxyapatite crystal lattice structure similar to bone, enamel and dentine. An organic portion is also present and consists of desquamated epithelial cells, leukocytes, salivary sediment, food debris and various types of microorganisms.
As the mature calculus develops, it becomes visibly white or yellowish in color unless stained or discolored by some extraneous agency. vIn addition to being unsightly and undesirable from an aesthetic standpoint, the mature calculus deposits are constant sources of irritation of the gingiva and thereby are a contributory factor to gingivitis and other diseases of the supporting structures of the teeth, the irritation decreasing the resistance of tissues to endogenous and exogenous organisms.
A wide variety of chemical and biological agents have been suggested in the art to retard calculus formation or to remove calculus after it is formed. Mechanical removal of this material periodically by the dentist is, of course, routine dental office procedure.
The chemical approach to calculus inhibition generally involves chelation of calcium ion which prevents the calculus from forming and/ or breaks down mature calculus by removing calcium. A number of chelating agents have been employed for this purpose. See, for example, British Pat. 490,384, granted Feb. 15, 1937, which discloses oral compositions containing ethylenediaminetetraacetic acid, nitrilotriacetic acid and related compounds as anticalculus agents; German Auslegeschrift 1,149,138, published May 22, 1963, which discloses certain water-soluble diglycolates as anticalculus agents; and U.S. Pat. 1,561,206 which discloses oral compositions containing various sugar lactones for this purpose.
Although certain of the art-disclosed chelators are purportedly safe for use on dental enamel, the chemical similarity of calculus to the tooth structure limits the usefulness of the chelation approach since the more effective chelators can seriously damage the tooth structure by decalcification. Thus, the development of oral compositions which effectively retard calculus by calcium chelation has been impeded by safety considerations.
SUMMARY OF THE INVENTION It has now been discovered that certain carbonyldiphosphonates possess the surprising capacity to retard the development of dental calculus without removing calcium from dental enamel or otherwise damaging the tooth structure when employed in oral compositions maintained within defined pH limits.
Unlike inorganic polyphosphates such as pyrophosphates, the carbonyldiphosphonates employed in the compositions of this invention resist hydrolysis in aqueous products and therefore remain in an active form throughout the normal shelf-life of such products.
It is therefore an object of this invention to provide novel oral compositions which retard the formation of calculus without otherwise affecting the tooth structure.
It is another object of this invention to provide an improved method for retarding the development of dental calculus.
Other objects will become apparent from the following detailed description.
DETAILED DESCRIPTION OF THE INVENTION This invention is an oral composition eflective in inhibiting the formation of dental calculus without adversely affecting the tooth structure comprising (1) from about .01% to about 10% by weight of a pharmaceutically acceptable carbonyldiphosphonate salt, such as alkali metal (e.g., sodium and potassium), alkaline earth metal (e.g., calcium and magnesium), non-toxic heavy metal (e.g., stannous and indium), and ammonium or low molecular weight substituted ammonium (e.g., mono-, di-, and triethanolammonium) salts; and (2) a carrier suitable for use in the oral cavity, the pH of said composition being in the range from about 5.0 to 11.0.
Upon neutralization, dihydroxymethanediphosphonic acid exists in equilibrum with the pharmaceutically acceptable carbonyldiphosphonate salt as follows:
When the salt-forming cation M replaces at least three of the acid hydrogens, the compound is predominantly in the carbonyldiphosphonate form. Unless otherwise specified, the term carbonyldiphosphonate as employed herein encompasses dihydroxymethanediphosphonic acid and salts as well as the carbonyldiphosphonate salts, collectively.
Carbonyldiphosphonates can be prepared in any convenient manner. A preferred method is disclosed by Oscar T. Quimby, U.S. Pat. 3,497,313, granted Feb. 24, 1970. The use of these compounds in inhibiting the anomalous deposition and mobilization of calcium phosphate by systemic administration is disclosed in the concurrently filed application of Marion D. Francis, Ser. No. 51,355, filed June 30, 1970.
The concentration of carbonyldiphosphonate in the oral compositions of this invention can range from about .0l% to about 10% by weight. Oral compositions which in the ordinary course of usage could he accidentally ingested should contain lower concentrations of carbonyldiphosphonate. Thus, a mouthwash in accordance with this invention preferably contains less than about 3% by weight of carbonyldiphosphonate. Dentifrice compositions, topical solutions and prophylaxis pastes, the latter to be administered professionally, can contain up to about 10% by weight, preferably from about 0.1% to about 5.0% by Weight of carbonyldiphosphonate.
The pH of the composition of this invention can range from about 5.0 to about 11. Below about pH 5.0 damage to the dental enamel can occur in spite of the relative safety of the carbonyldiphosphonates. Above about pH 11.0 difiiculty is encountered in formulating products having satisfactory flavor and mildness. A preferred pH range is from about 7.0 to about 10. The pH of the composition, of course, is determinative of the predominant salt form of the carbonyldiphosphonates present therein.
While it is not intended that this invention be limited by a particular theory of operation, it has been observed that the carbonyldiphosphonates encompassed herein interfere with the progress of calculus formation by interfering with the conversion of amorphous calcium phosphate to crystalline calcium hydroxyapatite. Amounts of carbonyldiphosphonates which are much too small to chelate any appareciable quantities of calcium have been found to retard the formation of calcium hydroxyapatite. This selective action on the formative calculus deposits without demineralizing action on the dental enamel is surprising.
The eflicacy of the compositions of this invention in calculus prophylaxis is demonstrated by the Rat Calculus and Crystal Growth Inhibition Tests which are conducted as follows:
Rat Calculus Study (Topical) Two groups of 20 to 21-day old Holtzman-Sprague- Dawley strain rats, each group comprising one male and one female member of each of 10 litters, are employed in this test, one group serving as the control and the other serving as the test group. Both groups of animals are placed on a calculus inducing diet consisting of 63% cornstarch, 32% non-fat dry milk, 2% liver powder and 3% cellulflour. Topical applications of a 0.5% aqueous solution of the carbonyldiphosphonate to be tested, adjusted to pH 10,0, are made on the teeth of each of the animals in the test group for about one minute twice daily, five days per week for two weeks. Similar applications of water are made to each animal in the control group during the experimental period.
Three weeks after the commencement of the test, the animals are sacrificed and their molar are graded for severity of calculus by assessing the area and depth of accumulation on eacth of the 44 dental surfaces examined in each animal. Grading is made on a -3 scale for each surface, 0 being no detectable calcified deposits, 3 being coverage of 50100% of the surface with a thick deposit and intermediate values representing gradations between these extremes. The total calculus score for each animal is determined by adding the grades for each of the 44 surfaces.
Substantial reductions in calculus formation are attained with topically applied compositions in accordance with this invention.
Crystal Growth Inhibition Determination v in this way interfere with the normal formation of calciu y y p ite item sqlut o The fl y f carbonyldiphosphonates in inhibiting crystal growth was demonstrated by the Crystal Growth Inhibition Determination which was conducted as follows:
1 ml. of a 0.1 M stock solution of NaH PO -H O' was diluted with 22 ml. of distilled Water. 1 ml. of an aqueous solution of tetrasodium carbonyldiphosphonate at a concentration sufiicient to provide the desired ultimate concentration in the reaction mixture was added to the diluted NaH PO solution and the solution was adjusted to pH 7.4 with sodium hydroxide. To this solution was added 1 ml. of a 0.1 M solution of CaCI -ZH O preadjusted to pH 7.4 with sodium hydroxide. This mixture was held at a constant pH 7.4 throughout the reaction period.
After a sufficient reaction time as determined by the operator, generally within minutes, the solution was filtered through a 0.45 Millipore filter pad. The precipitate was air-dried and analyzed by X-ray diffraction. The solid calcium phosphate precipitated from the above-described solution Without a carbonyldiphosphonate gives a typical hydroxyapatite pattern, while the calcium phosphate precipitated under the same conditions but in the presence of small amounts of this representative carbonyldiphosphonate was amorphous to X-rays.
Those compounds which are effective in inhibiting the growth of hydroxyapatite crystals at concentrations of less than 1.5 1O M under the conditions of this test are found to inhibit anomalous mobilization and deposition of calcium phosphates in animal tissue, while several compounds outside the scope of this invention that have little or no effect in this test are ineffective in vivo.
When tested in the above-described manner carbonyldiphosphonate was found to inhibit crystal growth at a concentration of 2.3 l0 M. Similar values are obtained when the other carbonyldiphosphonates encompassed by this invention are tested in like manner.
By way of comparison, ethylenediaminetetraacetic acid and nitrilotriacetic acid which have 'been suggested for use as anticalculus agents in the art fail to inhibit crystal growth at molar concentrations of 2.45 l0 respectively. At higher concentrations, these prior art compounds prevent precipitation of calcium phosphate in this test because of their powerful calcium sequestering properties.
A dentifrice, especially toothpaste, containing a carbonyldiphosphonate is preferred embodiment of this invention. Toothpaste compositions conventionally contain abrasive materials, sudsing agents, binders, humectants, flavoring and sweetening agents.
The abrasive materials and other adjuncts in the practice of this invention are preferably not sources of much soluble calcium so that the crystal growth inhibiting capacity of carbonyldiphosphonate is not depleted to an extent that its anticalculus activity is impaired. Thus, conventional abrasives such as dicalcium orthophosphate and calcium carbonate are preferably not used. However, predominantly B-phase calciumpyrophosphate prepared in accordance with the teachings of Schweizer, US. Pat. 3,112,247, granted Nov. 26, 1963, which contains relatively little soluble calcium can be used. An especially preferred class of abrasives for use herein are the particulate thermosetting polymerized resins as described by Cooley et al., in US. Pat. 3,070,510, granted Dec. 25, 1962. Suitable resins include, for example, melamines, phenolics, ureas, melamine-ureas, melamine-formaldehydes, urea-formaldehydes, melamine-urea-formaldehydes, cross-linked epoxides, and cross-linked polyesters.
Other suitable abrasives include alumina and the insoluble non-calcium metaphosphates such as sodium metaphosphate. Mixtures of abrasives can also be used. In any case, the total amount of abrasive in the dentifrice embodiments of this invention can range from 0.5% to by weight of the dentifrice. Preferably, toothpastes contain from 20% to 60% by weight of abrasive. Abrasive particle size preferably ranges from 2,41. to 20 Suitable sudsing agents are those which are reasonably stable and form suds throughout a wide pH range, preferably non-soap anionic organic synthetic detergents. Examples of such agents are water-soluble salts of alkyl sulfate having from to 18 carbon atoms in the alkyl radical, such as sodium lauryl sulfate; water-soluble salts of sulfonated monoglycerides of fatty acids having from 10 to 18 carbon atoms, such as sodium monoglyceride sulfonates; salts of C -C fatty acid amides of taurine, such as sodium N-methyl-N-palmitoyl tauride; salts of C -C fatty acid esters of isethionic acid; and substantially saturated aliphatic acyl amides of saturated monoaminocarboxylic acids having 2 to 6 carbon atoms and in which the acyl radical contains 12 to 16 carbon atoms, such as sodium N-lauroyl sarcoside. Mixtures of two or more sudsing agents can be used.
The sudsing agent can be present in the dentifrice compositions of this invention in an amount from 0.5% to 5% by weight of the total compositions.
In preparing toothpastes, it is necessary to add some thickening material to provide a desirable consistency. Preferred thickening agents are hydroxyethyl cellulose and water-soluble salts of cellulose ethers such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, gum arabic, and gum tragacanth can also be used. Colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture. Thickening agents in an amount from 0.5% to 5.0% by weight of the total composition can be used.
It is also desirable to include some humectant material in a toothpaste to keep it from hardening. Suitable humectants include glycerine, sorbitol, and other edible polyhydric alcohols. The humectant can comprise up to about 36% by weight of the toothpaste composition.
Suitable flavoring agents include oil of Wintergreen, oil of peppermint, oil of spearmint, oil of sassafras, and oil of clove. Sweetening agents which can be used include saccharin, dextrose, levulose and sodium cyclamate.
Several representative oral compositions illustrating this invention are set forth in the following examples.
EXAMPLE I A toothpaste of the following composition was prepared by conventional methods:
-Prepared in accordance with U.S. Pat. 3,112,247, granted Nov. 26, 1963.
This composition effectively retards calculus formation without decalcifying dental enamel.
Toothpaste compositions substantially identical to the composition of Example I are prepared with tetrasodium carbonyldiphosphonate, tetrapotassium carbonyldiphosphonate, dimagnesium carbonyldiphosphonate, monocalcium disodium carbonyldiphosphonate and tetraammonium carbonyldiphosphonate, respectively, rather than dihydroxymethanediphosphonic acid, adjusting the pH to 5.9. These compositions substantially retard calculus formation and do not decalcify dental enamel.
6 EXAMPLE 11 Yet another toothpaste was prepared having the following composition:
Parts by weight Water 39.58 Sorbitol 6.25 Saccharin .12 Abrasive (precipitated urea/ formaldehyde condensate) 31.00 Glycerine 18.00 Sodium alkyl (coconut) sulfate .40 Sodium cococut monoglyceride sulfonate .75 Sodium carboxymethyl cellulose 1.15 Magnesium aluminum silicate .40 Flavoring .95 Disodiumdipotassium carbonyldiphosphonate 1.50
Parts by weight of example- Component III IV V VI Glycerine-- 10.0 10.0 10. 0 10.0 16. 5 16. 5 16. 5 1G. 5
Sodium cyclam 075 075 076 04 Flavor 088 088 088 088 Carbonyldiphosphonate. 3. 0 I 3. 0 4 3.0 5 1. 0 p 6 7. 0 8. 5 10. 0 10. 0
days exposure of dental enamel to these compositions.
EXAMPLE VI A prophylaxis paste for use by the dentist for removal of stains and polishing the teeth after mechanical removal of calculus deposits is formulated as follows:
Parts by weight Navajo pumice 77.10 TiO 4.00 Glycerine 17.75 Hydroxyethylcellulose .22 Saccharin .33 Tetrasodium carbonyldiphosphonate 8.0 pH 8.0.
When applied to the teeth with a prophylactic rubber cup in the conventional manner, this composition retards the development of new calculus deposits.
Toothpowders and the like can be prepared by conventional methods and containing, in addition to the usual ingredients, an amount of carbonyldiphosphonate within the ranges specified herein, to provide an effective means of retarding calculus formation without damaging the tooth structure.
Those components other than carbonyldiphosphonates which were included in the foregoing examples and various mixtures of those components are illustrative of carriers suitable for use in the oral cavity.
In the reference to pH adjustments in the foregoing examples, it is to be understood that a baseof a cation corresponding to the salt form of the carbonyldiphosphonate employed is used to adjust to higher pH values. In each case in which the carbonyldiphosphonate was added in its acid form to the example compositions, the pH was adjusted to the specified higher value with NaOH. Adjustments in pH to more acid levels is accomplished with HCI acid. It will be obvious to those skilled in the art that pH adjustments can be made with any acid or base suitable for use in the oral cavity.
What is claimed is: t
1. An oral composition effective in inhibiting the for! mation. ofdental calculus without adversely afiecting tooth structure, comprising (1) from about 0.01% ,to about 10% by weight of a member selected from the group consisting of alkali metal carbonyldiphosphonates andalkaline earth metal carbonyldiphosphonates; and (2) a carrier 8 suitable for use in the oral cavity, the pH of the composition being within the range from about 5.0 to about 11.0 2. A toothpaste composition comprising (1) from about 0.01% to about 10% by weight of a member selected from the group consisting of alkali metal carbonyldiphosphonates and alkaline earth inetal carbonyldiphosphonates; and I 2) a carrier suitable for use in the oral cavity, the pH of the composition being within the'range from about 5.0 to about 11.0.
References Cited UNITED STATES PATENTS 3,488,419 1/1970' McCune et al 42449 3,497,313 2/1970 Quimby 260-502.4 P 3,549,677 12/ 1970 Griebstein' et a1. 42449 OTHER REFERENCES RICHARD'L. HUFF, Primary Eztaminer I
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5135670A | 1970-06-30 | 1970-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3737522A true US3737522A (en) | 1973-06-05 |
Family
ID=21970797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00051356A Expired - Lifetime US3737522A (en) | 1970-06-30 | 1970-06-30 | Oral compositions for calculus retardation |
Country Status (1)
Country | Link |
---|---|
US (1) | US3737522A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515772A (en) * | 1982-06-22 | 1985-05-07 | The Procter & Gamble Company | Oral compositions |
US4590066A (en) * | 1982-06-22 | 1986-05-20 | The Procter & Gamble Company | Oral compositions |
US4661341A (en) * | 1984-10-30 | 1987-04-28 | The Procter & Gamble Company | Oral compositions |
US4684518A (en) * | 1982-06-22 | 1987-08-04 | The Procter & Gamble Company | Oral compositions |
US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
US4885155A (en) * | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
US4999184A (en) * | 1982-06-22 | 1991-03-12 | The Procter & Gamble Company | Oral compositions |
US5451401A (en) * | 1993-09-29 | 1995-09-19 | The Procter & Gamble Company | Diphosphonic acid esters as tartar control agents |
US5514366A (en) * | 1993-04-07 | 1996-05-07 | Diamond; Jeffrey H. | Dental and oral preparation for smokers for solubilizing and removing tobacco tars as well as onion and garlic essential oils |
US5753723A (en) * | 1995-12-06 | 1998-05-19 | Chang; Tiang Shing | Denture fixative with an adhesion promoter |
US6086372A (en) * | 1997-06-04 | 2000-07-11 | Block Drug Company, Inc. | Dental and oral preparation |
US6214320B1 (en) * | 1990-10-09 | 2001-04-10 | Colgate-Palmolive Company | Oral compositions containing anticalculus and antiplaque agents |
US6241974B1 (en) * | 1997-04-22 | 2001-06-05 | The Procter & Gamble Company | Dentifrice compositions containing β-phase calcium pyrophosphate an anticalculus agent, and fluoride |
US6682722B2 (en) | 2001-09-19 | 2004-01-27 | The Procter & Gamble Company | Oral compositions providing enhanced overall cleaning |
-
1970
- 1970-06-30 US US00051356A patent/US3737522A/en not_active Expired - Lifetime
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999184A (en) * | 1982-06-22 | 1991-03-12 | The Procter & Gamble Company | Oral compositions |
US4684518A (en) * | 1982-06-22 | 1987-08-04 | The Procter & Gamble Company | Oral compositions |
US4885155A (en) * | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
US4590066A (en) * | 1982-06-22 | 1986-05-20 | The Procter & Gamble Company | Oral compositions |
US4515772A (en) * | 1982-06-22 | 1985-05-07 | The Procter & Gamble Company | Oral compositions |
US4661341A (en) * | 1984-10-30 | 1987-04-28 | The Procter & Gamble Company | Oral compositions |
US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
US6214320B1 (en) * | 1990-10-09 | 2001-04-10 | Colgate-Palmolive Company | Oral compositions containing anticalculus and antiplaque agents |
US5514366A (en) * | 1993-04-07 | 1996-05-07 | Diamond; Jeffrey H. | Dental and oral preparation for smokers for solubilizing and removing tobacco tars as well as onion and garlic essential oils |
US5662888A (en) * | 1993-04-07 | 1997-09-02 | Jeffrey Mitchell Laboratories | Toothpaste for smokers for solubilizing and removing tobacco tars |
US5451401A (en) * | 1993-09-29 | 1995-09-19 | The Procter & Gamble Company | Diphosphonic acid esters as tartar control agents |
US5753723A (en) * | 1995-12-06 | 1998-05-19 | Chang; Tiang Shing | Denture fixative with an adhesion promoter |
US6241974B1 (en) * | 1997-04-22 | 2001-06-05 | The Procter & Gamble Company | Dentifrice compositions containing β-phase calcium pyrophosphate an anticalculus agent, and fluoride |
US6086372A (en) * | 1997-06-04 | 2000-07-11 | Block Drug Company, Inc. | Dental and oral preparation |
US6682722B2 (en) | 2001-09-19 | 2004-01-27 | The Procter & Gamble Company | Oral compositions providing enhanced overall cleaning |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3488419A (en) | Oral compositions for calculus retardation | |
US3553314A (en) | Oral compositions for calculus retardation | |
US3639569A (en) | Oral compositions for calculus retardation | |
US3678154A (en) | Oral compositions for calculus retardation | |
US3959458A (en) | Oral compositions for calculus retardation | |
US5338537A (en) | Oral compositions | |
EP0297211B1 (en) | Oral compositions | |
US3553315A (en) | Oral compositions for calculus retardation | |
US3535421A (en) | Oral compositions for calculus retardation | |
US3737522A (en) | Oral compositions for calculus retardation | |
GB2121278A (en) | Oral hygiene compositions | |
US3175951A (en) | Oral compositions for caries prophylaxis | |
USRE29182E (en) | Oral composition for calculus retardation | |
EP0453018B1 (en) | Poly (alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions | |
US4143128A (en) | Oral compositions for calculus retardation | |
EP0469040B1 (en) | Dental hygiene composition for reducing periodontal disease | |
US3535420A (en) | Oral compositions for calculus retardation | |
US4144324A (en) | Oral compositions for calculus retardation | |
PH26504A (en) | Oral compositions | |
DE2332383A1 (en) | ORAL AND DENTAL CARE PRODUCTS | |
DE2255177C3 (en) | Preparations for preventing tartar | |
EP0457378A2 (en) | Hypophosphite-containing cotelomers as antitartar agents | |
US3584116A (en) | Oral compositions for calculus retardation | |
US3448132A (en) | Stannous hydroxyethylnitrilodiacetate | |
EP0020617A1 (en) | Dentifrice. |